Last updated: February 26, 2024
Sponsor: Ain Shams University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pain
Chronic Pain
Treatment
the effect of adding pulsed radiofrequency (PRF) modality to suprascapular nerve injection with ultrasound glenohumeral steroid in chronic shoulder pain patients
Clinical Study ID
NCT06106490
FMASU MD128/2023
Ages 21-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adults aged from 21-60 years.
- Patients with American Society of Anesthesiologists (ASA) physical status I and II.
- Chronic shoulder pain (>3 months) and will undergo interventional treatment due toinadequate response to conservative treatments.
Exclusion
Exclusion Criteria:
- Refusal of procedure or participation in the study by patients.
- History of shoulder surgery, another intervention history between 3 months before and 1 year after the intervention applied.
- Patients with chronic pain syndrome due to other shoulder pathology (fibromyalgia,cervical discopathy, brachial plexus injury).
- Uncontrolled diabetes mellitus patients with glycated hemoglobin (HbA1C) levels ofmore than 7%.
- Patients with known history of allergy to the study drugs.
- Infection at site of injection.
- Cognitive or psychiatric illness that will lead to inability to cooperate, speak, orprovide informed consent.
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: the effect of adding pulsed radiofrequency (PRF) modality to suprascapular nerve injection with ultrasound glenohumeral steroid in chronic shoulder pain patients
Phase:
Study Start date:
November 01, 2023
Estimated Completion Date:
November 30, 2024
Study Description
Connect with a study center
Faculty of medicine Ain Shams University
Cairo, 11566
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.